Hormone replacement therapy. The cardiologist's point of view;Hormonoterapia zastepcza - Punkt widzenia kardiologa

Przeglad Menopauzalny

Volumn 6, Issue 1, 2007, Pages 3-7

  Peruga, Jan Z ^a   Kopff, Anna ^a   Pakuła, Maria Krzemińska ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cardiovascular disease; Hormonal replacement therapy

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE; NOMEGESTROL ACETATE; PLACEBO;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; ENDOMETRIUM; ENDOTHELIUM CELL; ESTROGEN THERAPY; FEMALE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; THROMBOEMBOLISM;

EID: 34147096600     PISSN: 16438876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kok HS, van Asselt KM, van der Schouw YT, et al. Heart Disease Risk Determines Menopausal Age Rather Than the Reverse. J Am Coll Cardiol 2006; 47: 1976-83.
2. van der Schouw YT, Grobbee DE. Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy. Eur Heart J 2005; 26: 1358-61.
3. Waters DD, Gordon D, Rossouw JE, et al. Women's ischemic syndrorne evaluation. Current status and future research directions. Report of the national heart, lung and blood institute workshop. October 2-4, 2002. Section 4. Lessons from hormone replacement trials. Circulation 2004; 109: 53-5.
4. Viscoli CM, Brass LM, Kernan WN, et al. A clinical trial of estrogen-replacement therapy after ischaemic stroke. N Engl J Med 2001; 345: 1243-9.
5. The ESPRIT team. Oestrogen therapy for prevention of reinfarction In postmenopausal women: a randomised placebo controlled trial. Lancet 2002; 360: 2001-8.
6. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of oestrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000; 343: 522-9.
7. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
8. Manson JE, Martin KA. Clinical practice. Postmenopausal hormone-replacement therapy. N Engl J Med 2001; 345: 34-40.
9. Ouyang P, Michos ED, Karas RH. Hormone replacement therapy and the cardiovascular system. J Am Coll Cardiol 2006; 47: 1741-53.
10. Herrington DM, Espeland MA, Crouse JR, et al. Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler Thromb Vasc Biol 2001; 21: 1955-61.
11. Dubey RK, Jackson EK, Gillespie DG, et al. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler Thromb Vasc Biol 2000; 20; 964-72.
12. Simoncini T, Mannella P, Fornari L, et al. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 2004; 145: 5745-56.
13. Pedersen S, Lokkegaard E, Ottesen B. Hormone therapy and cardiovascular risk markers and disease: focus on progestagens. Future Cardiol 2006; 2: 677-86.
14. Simoncini T, Caruso A, Garibaldi S, et al. Activation of nitric oxide synthesis in human endothelial cells using nomegestrol acetate. Obstet Gynecol 2006; 108: 969-78.
15. Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with thromboembolism risk. Lancet 2003; 362: 428-42.
16. Herrington DM, Vittinghoff E, Lin F, et al. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/ Progestin Replacement Study (HERS). Circulation 2002; 105: 2962-7.
17. Grady D. Postmenopausal hormones - therapy for symptoms only. N Engl J Med 2003; 348: 1835-7.
18. Mosca L, Collins P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104:499-503
19. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109: 672-93.